TEICOPLANINE HIKMA 200 mg, powder for solution for injection/for infusion or oral solution bottle
Active ingredients: TÉICOPLANINE
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for infusion or oral usebottleintramusculaire;intraveineuse;orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TEICOPLANINE HIKMA 200 mg, poudre pour solution injectable/pour perfusion ou solution buvable
- Pharmaceutical form
- poudre pour solution injectable pour perfusion ou buvable
- Route of administration
- intramusculaire;intraveineuse;orale
- Presentation description
- 1 flacon(s) de poudre en verre
- Marketing authorisation holder
- HIKMA FARMACEUTICA (PORTUGAL)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Sept 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64935262CIP75506297CIP133400955062974Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TÉICOPLANINEpoudre | 200 mg équivalents à au moins 200 000 UI · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.